Quantcast

Posts related to ‘hepatitis C’

Analyst Sees 55% Upside in Small Biotech

Posted: November 28, 2012 at 10:49 am

Idenix Pharmaceuticals Inc. (NASDAQ: IDIX) was covered this morning in our analyst upgrades and downgrades daily summary, but call is worth a closer look. Deutsche Bank initiated the small biotech with ...
Read Full Story »

Crushing Blow for Gilead, Billions of Dollars (GILD)

Posted: February 17, 2012 at 7:22 am

Gilead Sciences Inc. (NASDAQ: GILD) is being crushed after a disappointing result in its Hepatitis C treatment after reporting that a majority of hepatitis C genotype-1 patients who had a ...
Read Full Story »

Media Digest 8/5/2010 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: August 5, 2010 at 4:02 am

Reuters:   Halliburton (NYSE: HAL) has objected to giving the government advanced notice of its dealings with oil companies on major projects. Reuters:   Google Inc. (NASDAQ: GOOG) will take on Facebook ...
Read Full Story »